Primary |
Basal Cell Carcinoma |
28.1% |
Actinic Keratosis |
19.1% |
Anogenital Warts |
11.3% |
Skin Papilloma |
8.2% |
Precancerous Cells Present |
5.9% |
Skin Cancer |
5.1% |
Squamous Cell Carcinoma |
3.5% |
Precancerous Skin Lesion |
3.1% |
Bowen's Disease |
1.6% |
Condyloma Acuminatum |
1.6% |
Skin Disorder |
1.6% |
Skin Lesion |
1.6% |
Squamous Cell Carcinoma Of Skin |
1.6% |
Biopsy |
1.2% |
Hyperkeratosis |
1.2% |
Hypertension |
1.2% |
Infection |
1.2% |
Molluscum Contagiosum |
1.2% |
Product Used For Unknown Indication |
1.2% |
Cheilitis |
0.8% |
|
Pyrexia |
13.0% |
Weight Decreased |
10.9% |
Vision Blurred |
8.7% |
Urticaria |
7.6% |
Wrong Technique In Drug Usage Process |
6.5% |
Lymphadenopathy |
5.4% |
Myocardial Infarction |
4.3% |
Scab |
4.3% |
Stevens-johnson Syndrome |
4.3% |
Swelling |
4.3% |
Nausea |
3.3% |
Swollen Tongue |
3.3% |
Thermal Burn |
3.3% |
Tinnitus |
3.3% |
Treatment Noncompliance |
3.3% |
Upper Respiratory Tract Infection |
3.3% |
Vertigo |
3.3% |
White Blood Cell Count Decreased |
3.3% |
Application Site Erythema |
2.2% |
Dizziness |
2.2% |
|
Secondary |
Actinic Keratosis |
27.8% |
Depression |
13.3% |
Basal Cell Carcinoma |
10.0% |
Anogenital Warts |
5.6% |
Drug Use For Unknown Indication |
4.4% |
Precancerous Skin Lesion |
4.4% |
Skin Cancer |
4.4% |
Sunburn |
4.4% |
Precancerous Cells Present |
3.3% |
Sciatica |
3.3% |
T-cell Lymphoma |
3.3% |
Breast Cancer |
2.2% |
Cyst |
2.2% |
Erectile Dysfunction |
2.2% |
Pain |
2.2% |
Product Used For Unknown Indication |
2.2% |
Abscess |
1.1% |
Anxiety |
1.1% |
Application Site Infection |
1.1% |
Atrial Fibrillation |
1.1% |
|
Sunburn |
13.3% |
Paraesthesia |
10.0% |
Drug Ineffective |
6.7% |
Myocardial Infarction |
6.7% |
Pleural Effusion |
6.7% |
Skin Reaction |
6.7% |
White Blood Cell Count Decreased |
6.7% |
Anaphylactic Reaction |
3.3% |
Application Site Discolouration |
3.3% |
Application Site Erythema |
3.3% |
Condition Aggravated |
3.3% |
Erythema Multiforme |
3.3% |
Eye Pain |
3.3% |
Feeling Hot |
3.3% |
Hydrocephalus |
3.3% |
Intestinal Obstruction |
3.3% |
Lung Disorder |
3.3% |
Ocular Icterus |
3.3% |
Pain In Jaw |
3.3% |
Pneumonia |
3.3% |
|
Concomitant |
Hiv Infection |
28.5% |
Pain |
7.3% |
Eczema |
6.6% |
Product Used For Unknown Indication |
6.4% |
Anxiety |
5.8% |
Contraception |
5.8% |
Menopause |
5.3% |
Hypertension |
4.2% |
Anogenital Warts |
3.5% |
Depression |
2.9% |
Drug Use For Unknown Indication |
2.9% |
Menopausal Symptoms |
2.7% |
Polyarthritis |
2.7% |
Rheumatoid Arthritis |
2.7% |
Diarrhoea |
2.4% |
Menstrual Cycle Management |
2.2% |
Pleurisy |
2.2% |
Gastrooesophageal Reflux Disease |
2.0% |
Hyperlipidaemia |
2.0% |
Skin Papilloma |
2.0% |
|
Vaginal Haemorrhage |
14.8% |
Viral Pharyngitis |
12.3% |
Weight Decreased |
9.9% |
Death |
4.9% |
Tooth Extraction |
4.9% |
Varices Oesophageal |
4.9% |
Ventricular Septal Defect |
4.9% |
Abdominal Pain |
3.7% |
Cholelithiasis |
3.7% |
Deep Vein Thrombosis |
3.7% |
Organising Pneumonia |
3.7% |
Pain |
3.7% |
Pneumonia |
3.7% |
Pulmonary Embolism |
3.7% |
Pulmonary Infarction |
3.7% |
Wound Treatment |
3.7% |
Biliary Colic |
2.5% |
Blood Creatine Phosphokinase Increased |
2.5% |
Blood Glucose Increased |
2.5% |
Brain Stem Haemorrhage |
2.5% |
|
Interacting |
|
|